Liposome Drug Delivery Market Scope
Liposomes is defined as the small spherical-shaped artificial vesicles, which are synthesized from phospholipids and cholesterol. It is colloidal carriers as well as a range from 0.01 to 5.0 μm in diameter. It is widely used to improve the therapeutic index of established drugs by reducing metabolism and reducing toxicity. New applications for the delivery of new biotechnology products, for instance, recombinant proteins antisense oligonucleotides, as well as cloned genes, are some of the major drivers which are propelling the growth of the market.
According to AMA, the Global Liposome Drug Delivery market is expected to see growth rate of 14.8%
The market is fragmented with numerous players focusing on technique and quality of the product due to which the global liposome drug delivery market can witness an upsurge in the forecast period. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Liposome Drug Delivery market throughout the predicted period.
Gilead Sciences, Inc., (United States), Pacira (United States), Sun Pharmaceutical (India), Luye Pharma (China), Sigma-Tau Group (Switzerland), Fudan-Zhangjiang (China), Teva Pharmaceutical Industries Ltd. (Israel), CSPC (United States), Novartis International AG (Switzerland) and Kingond Pharm (China) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Spectrum Pharmaceuticals (United States) and Shanghai New Asia (china).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
Segmentation Overview
The study have segmented the market of Global Liposome Drug Delivery market by Type (Liposomal Doxorubicin, Liposomal Amphotericin B and Liposomal Paclitaxel), by Application (Pharmaceutical, Cosmetic, Food and Farming) and Region with country level break-up.
On the basis of geography, the market of Liposome Drug Delivery has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
On April 2019, the Insmed, Inc. (United States) Company has provided provides Update on ARIKAYCE, which is liposome inhalation suspension. This will, in turn, propel the growth of liposome drug delivery mark
On August 2018, the United States Food and Drug Administration (FDA), has published its final guidance for industry on liposome drug products in April 2018. In addition, it finalizes the revised draft guidance for industry Liposome Drug Products
Market Trend
- Rapid Advancements in targeted Drug Delivery Systems
Market Drivers
- Rising Prevalence of Chronic Diseases
- Technological Advancements and New Product Launches
- Growth in the Biologics Market
Opportunities
- Rising Demand from Emerging Economics such as India, China and others
- Rising Demand for Biosimilars and Self-Administration and Home Care
Restraints
- The problem regarding the Low Solubility, Short Half-Life, and High Production Cost are the Restraints of the Market in future
Challenges
- Problem related to Pricing Pressure
Key Target Audience
Manufacturers of Liposome Drug Delivery, Suppliers of Liposome Drug Delivery, Wholesalers, Distributors and Retailers of Liposome Drug Delivery, Research and Development (R&D) Companies, Research Organization, Federal Agencies and Others